Pathogen Synergy Through Cross-Species Induction of Outer Membrane Vesicle Biogenesis
通过跨物种诱导外膜囊泡生物发生的病原体协同作用
基本信息
- 批准号:10204938
- 负责人:
- 金额:$ 15.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-29 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:ANXA5 geneAntibioticsApoptosisAreaBacteriaBehaviorBiogenesisCellsCoculture TechniquesCommunicable DiseasesCommunicationCommunitiesComplexDataDiseaseDisease modelEnzymesEpidemiologyEpithelial CellsEscherichia coliFoundationsFutureGammaproteobacteriaHumanImmune responseImmune systemIn VitroIndividualInduction of ApoptosisInfectionLabelLeadLifeLipidsLungMass FragmentographyMediator of activation proteinMembraneMethodsModelingOrganismPathogenesisPathogenicityPatient-Focused OutcomesPatientsPhenotypePlayPopulationProblem SolvingProductionPseudomonas aeruginosaReportingRoleSignal TransductionSiteTestingTimeToxinTrypan BlueVesicleVirulenceVirulence FactorsVirulentWorkantibiotic tolerancebacterial communitycell typeco-infectioncytotoxiccytotoxicityexperimental studyfollow-upgenetic elementhuman pathogenin vivoinsightmacrophagemicrobiotanovelpathogenpathogenic bacteriasmall moleculesynergism
项目摘要
Abstract
Bacteria have been cooperating and competing for all of evolutionary time. Only recently, however, have we
seriously begun to take this into account in the context of infectious disease mechanisms. The expanding ability
to study bacteria in complex consortia (i.e. how they normally live) has sparked a renewed appreciation for the
complexity of real bacterial populations and an examination of how they interact. Co-infection studies show that
pathogen communities are more virulent, and this aligns with epidemiological reports that connect multispecies
infections to worse patient outcomes. A common hypothesis is that this pathogen synergy comes about because
of competition and communication between multiple species at an infection site. We hypothesize that Outer
Membrane Vesicles (OMVs) serve as a major mediator of these interactions because they are known to facilitate
both competition and communication between bacteria (in addition to direct virulence against host cells).
We proposed a model in P. aeruginosa where OMV biogenesis is driven by the secretion and insertion of a self-
produced small molecule into the outer leaflet of the outer membrane. We recently showed that this molecule
could induce related species to overproduce OMVs when given at low concentration, and that those recipient
species produced their own OMV cross-inducing factors. This raised the possibility that cross-species induction
of OMV biogenesis could serve as a mechanism for multispecies communities to synergize for increased
virulence. Guided by strong preliminary data, we will pursue two specific aims to characterize how multiple
pathogens at an infection site might interact through cross-species induction of OMV biogenesis and what effects
this would have on host cells: (1) We will begin by testing for small molecule-induced OMV formation using the
known P. aeruginosa OMV-inducing compound PQS against a broad panel of important human pathogens likely
to encounter each other at an infection site. Our established methods have already identified several such
interactions among the γ-proteobacteria. We will then test whether actually growing species together (in contrast
to using monocultures with exogenous compounds as above) will result in increased OMV production for the
community. Preliminary results show that this is true for our pilot pairing of P. aeruginosa + E. coli. (2) OMVs
from mono- vs. co-culture will be tested for their cytotoxic potential against macrophage and lung epithelial cells
as well as their ability to degrade or sequester antibiotics (another disease-related function of OMVs). Preliminary
results with P. aeruginosa + E. coli co-culture OMVs show that cytotoxicity and induction of apoptosis are both
increased over monoculture OMVs, demonstrating feasibility of the approach and providing support for the
hypothesis that cross-species OMV induction may contribute to pathogen synergy.
Understanding pathogen interactions at infection sites is critical to understanding why multispecies infections
lead to more severe disease. Given the ubiquity of OMV production among Gram-negative organisms, the
insights gained from this study promise to broadly impact our understanding of multi-species pathogenesis.
抽象的
细菌一直在整个进化时期合作和竞争。
认真地考虑了传染病机制的背景
研究复杂的细菌(即,他们的正常生活如何)引发了对它们的重新欣赏
实际的双脚群体的复杂性和对它们相互作用的研究表明。
病原体群落更具敏感性,这与连接多种产品的流行病学报告保持一致
感染对患者预后更糟的感染。
在感染部位的竞争和沟通。
膜囊泡(OMV)是相互作用的主要中介者,因为已知它们可以促进
竞争和巴克氏菌之间的交流(除了直接针对宿主细胞的病毒性)。
我们在铜绿假单胞菌中支撑了一个模型,其中OMV生物发生是由自我的分泌和插入驱动的
产生的小分子进入外膜的外部小叶。
在低浓度下给出时,可能会诱导相关物种过度生产OMV,而那些受体
物种产生了自己的OMV交叉诱导因素。
OMV生物发生可以作为多种植者协同作用以增加的机制
在强大的初步数据的指导下,我们将追求两个特定的目标
感染部位的病原体可能通过跨物种诱导OMV生物发生以及什么影响相互作用
这将在宿主细胞上具有:(1)我们将首先测试小分子诱导的OMV形成
已知的铜绿假单胞菌OMV诱导化合物PQs针对一组重要的人类病原体可能
在感染部位相互遇到。
γ-蛋白菌之间的相互作用。
使用具有外源化合物的单一培养物将增加OMV的产生。
社区
从单与培养物中,将对其针对巨噬细胞和肺部占地细胞的细胞毒性潜力进行测试
以及降解或隔离抗生素(OMV的另一个功能)的Arity
铜绿 + e的结果。
对单一文化OMV的增加,证明了该方法的可行性并为其提供支持
跨物种OMV指示可能有助于病原体协同作用的假设。
了解感染部位的病原体相互作用对于理解为什么多物种感染至关重要
导致更严重的疾病。
洞察力从跌至巨大影响我们对多物种发病机理的理解的陷入障碍中获得的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Schertzer其他文献
Jeffrey Schertzer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Schertzer', 18)}}的其他基金
Pathogen Synergy Through Cross-Species Induction of Outer Membrane Vesicle Biogenesis
通过跨物种诱导外膜囊泡生物发生的病原体协同作用
- 批准号:
10043365 - 财政年份:2020
- 资助金额:
$ 15.02万 - 项目类别:
Evaluating the Bilayer-Couple Model of Outer Membrane Vesicle Biogenesis Using Novel Asymmetric Membrane Templates
使用新型不对称膜模板评估外膜囊泡生物发生的双层耦合模型
- 批准号:
9199067 - 财政年份:2016
- 资助金额:
$ 15.02万 - 项目类别:
Evaluating the Bilayer-Couple Model of Outer Membrane Vesicle Biogenesis Using Novel Asymmetric Membrane Templates
使用新型不对称膜模板评估外膜囊泡生物发生的双层耦合模型
- 批准号:
9016995 - 财政年份:2016
- 资助金额:
$ 15.02万 - 项目类别:
相似国自然基金
人α-防御素-1(HNP-1)抗菌新机制的定量蛋白质组学研究
- 批准号:31870824
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
细胞凋亡剂多氧环菌素取代侧链中2-(2-甲基-丁基)丙二酰-单酰-ACP特殊聚酮延伸单位的生物合成及其加载机制研究
- 批准号:31700027
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
复方聪耳胶囊及其拆方干预离体和在体AmAn中毒性耳蜗神经细胞凋亡形态学及相关因子影响机制研究
- 批准号:81373700
- 批准年份:2013
- 资助金额:65.0 万元
- 项目类别:面上项目
68Ga-NOTA-Duramycin 新型凋亡显像剂的合成及用于早期评价肿瘤疗效的实验研究
- 批准号:81271604
- 批准年份:2012
- 资助金额:70.0 万元
- 项目类别:面上项目
康宁木霉合成的peptaibols类抗生素肽结构、性质及其抗肿瘤机理研究
- 批准号:30870047
- 批准年份:2008
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
The Gut as a Target to Improve Outcomes in Sepsis
肠道作为改善脓毒症预后的目标
- 批准号:
10552403 - 财政年份:2023
- 资助金额:
$ 15.02万 - 项目类别:
Mining host-microbe interactions in the neonatal pancreas to combat diabetes
挖掘新生儿胰腺中宿主-微生物的相互作用来对抗糖尿病
- 批准号:
10664448 - 财政年份:2023
- 资助金额:
$ 15.02万 - 项目类别:
Cell death proteins as inflammatory mediators in sepsis
细胞死亡蛋白作为脓毒症炎症介质
- 批准号:
10715338 - 财政年份:2023
- 资助金额:
$ 15.02万 - 项目类别:
Stenotrophomonas maltophilia TfcA and TfcB: Antibacterial T4SS effectors from an emerging human pathogen
嗜麦芽寡养单胞菌 TfcA 和 TfcB:来自新兴人类病原体的抗菌 T4SS 效应子
- 批准号:
10661253 - 财政年份:2023
- 资助金额:
$ 15.02万 - 项目类别:
Reciprocal brain-lung responses in post-stroke pneumonia
中风后肺炎的脑肺交互反应
- 批准号:
10754060 - 财政年份:2023
- 资助金额:
$ 15.02万 - 项目类别: